Diabetic neuropathy. Autonomic neuropathy in diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient willingness and having written informed consent to participate in the study Get a minimum score of 6 on the Toronto Diabetic Neuropathy Questionnaire Awareness and ability to speak and communicate to report the severity of clinical symptoms during the examination Age between 18 to 60 years Having a natural earlobe
Exclusion criteria
Exclusion criteria: History of disease or condition affecting neuropathy based on medical history and patient report The presence of any known complication and other medical problem leads to pain Existence of a lesion or skin problem in the area of the ear and the site of acupressure
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning of the study (before the intervention) and six weeks after the start of the study. Method of measurement: Neuropathy specific quality of life. | — |
Primary
| Measure | Time frame |
|---|---|
| Symptoms of neuropathy include pain and sensory disturbances (including burning, numbness, tingling, weakness, muscle cramps). Timepoint: Beginning of the study (before the intervention) and after the intervention (six weeks after the intervention). Method of measurement: Neuropathy Symptom Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Gonabad University of Medical Sciences